|
|
||||||||
Original Articles |
This one year prospective multicentre study was designed to determine the incidence of community-acquired pneumonia in adults. It was carried out in primary health care centres and three reference hospitals, located in the 'Maresme' region (Barcelona, Spain) serving a population of 39,733 subjects over 13 years of age. Patients suspected of having contracted community-acquired pneumonia were visited by their family doctors and referred to the three reference hospitals for confirmation of the diagnosis. Patients attending the emergency services of these hospitals were also included. Urine and blood samples were obtained for culture, antigen detection, blood count, serological tests, blood gases and biochemical profile. The diagnosis of community-acquired pneumonia was made in 105 patients. Forty-six patients had an identifiable microbial etiology. Chlamydia pneumoniae was the most common pathogen (16 cases) followed by Streptococcus pneumoniae (13 cases) and Mycoplasma pneumoniae (8 cases). In conclusion; the annual incidence rate of community-acquired pneumonia in adults in this area was 2.6 cases per 1,000 inhabitants and Chlamydia pneumoniae was the most frequent causative pathogen.
This article has been cited by other articles:
![]() |
P. G. Dambrava, A. Torres, X. Valles, J. Mensa, M. A. Marcos, G. Penarroja, M. Camps, R. Estruch, M. Sanchez, R. Menendez, et al. Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome Eur. Respir. J., October 1, 2008; 32(4): 892 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gullsby, M. Storm, and K. Bondeson Simultaneous Detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by Use of Molecular Beacons in a Duplex Real-Time PCR J. Clin. Microbiol., February 1, 2008; 46(2): 727 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Miyashita, H. Fukano, K. Mouri, M. Fukuda, K. Yoshida, Y. Kobashi, Y. Niki, and M. Oka Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalized patient study J. Med. Microbiol., April 1, 2005; 54(4): 395 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Blasi Atypical pathogens and respiratory tract infections Eur. Respir. J., July 1, 2004; 24(1): 171 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.J. Marrie, R.W. Peeling, T. Reid, E. De Carolis, and the Canadian Community-Acquired Pneumonia Investig Chlamydia species as a cause of community-acquired pneumonia in Canada Eur. Respir. J., May 1, 2003; 21(5): 779 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Menendez, D. Ferrando, J. M. Valles, and J. Vallterra Influence of Deviation From Guidelines on the Outcome of Community-Acquired Pneumonia* Chest, August 1, 2002; 122(2): 612 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Woodhead Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Eur. Respir. J., July 1, 2002; 20(36_suppl): 20S - 27s. [Abstract] [Full Text] [PDF] |
||||
![]() |
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults Thorax, December 1, 2001; 56(90004): iv1 - 64. [Full Text] [PDF] |
||||
![]() |
M. S. Niederman, L. A. Mandell, A. Anzueto, J. B. Bass, W. A. Broughton, G. D. Campbell, N. Dean, T. File, M. J. Fine, P. A. Gross, et al. Guidelines for the Management of Adults with Community-acquired Pneumonia . Diagnosis, Assessment of Severity, Antimicrobial Therapy, and Prevention Am. J. Respir. Crit. Care Med., June 1, 2001; 163(7): 1730 - 1754. [Full Text] [PDF] |
||||
![]() |
C. M. Luna, A. Famiglietti, R. Absi, A. J. Videla, F. J. Nogueira, A. D. Fuenzalida, and R. J. Gene Community-Acquired Pneumonia : Etiology, Epidemiology, and Outcome at a Teaching Hospital in Argentina Chest, November 1, 2000; 118(5): 1344 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F Holmes and M. Woodhead Issues at the interface between primary and secondary care in the management of common respiratory disease bullet 4: Providing better care for patients who may have pneumonia Thorax, October 1, 1999; 54(10): 925 - 928. [Full Text] |
||||
![]() |
J. Almirall, C. A. Gonzalez, X. Balanzo, and I. Bolibar Proportion of Community-Acquired Pneumonia Cases Attributable to Tobacco Smoking Chest, August 1, 1999; 116(2): 375 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Koivula, M. Sten, and P. H. Makela Prognosis After Community-Acquired Pneumonia in the Elderly: A Population-Based 12-Year Follow-up Study Arch Intern Med, July 26, 1999; 159(14): 1550 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. MENÉNDEZ, J. CÓRDOBA, P. de la CUADRA, M. J. CREMADES, J. L. LÓPEZ-HONTAGAS, M. SALAVERT, and M. GOBERNADO Value of the Polymerase Chain Reaction Assay in Noninvasive Respiratory Samples for Diagnosis of Community-acquired Pneumonia Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1868 - 1873. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |